HIT Consultant November 10, 2023
What You Should Know:
– RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma.
– The need for the RapidAI solution is urgent, with SDH cases in US patients expected to increase by nearly 80% before 2040.
AI Module for Detection of Hemispheric Subdural Hematomas
Rapid SDH leverages AI to help neurocritical care teams identify suspected hemispheric subdural hemorrhage faster and with a higher degree of accuracy than traditional methods.
Key features of Rapid SDH include:
– The only hemorrhagic and trauma package to feature hemispheric SDH, ICH and Hyperdensity for faster...
Today's Sponsors
Today's Sponsor